Pluri Inc.

Regulatory Filings • Apr 6, 2011

8-K 1 document.htm FORM 8-K FILING DOCUMENT html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Form 8-K Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 6, 2011

PLURISTEM THERAPEUTICS INC. (Exact name of registrant as specified in its charter)

Registrant's State of Inc, File and IRS Number

Nevada	001-31392	98-0351734
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Registrant's Postal Addess and Zip Code

| MATAM Advanced Technology Park
Building No. 20
Haifa, Israel | 31905 |
| --- | --- |
| (Address of principal executive offices) | (Zip Code) |

Registrant's telephone number, including area code: 011 972 74 710 7171

______________ (Former name or former address, if changed since last report)

Simultaneous filing obligation checkboxes

| Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions: | |
| --- | --- |
| [ ] | Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |

Item 8.01. Other Events.

On April 6, 2011 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit 99.1. Press release dated April 6, 2011

Registrant's Signature

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PLURISTEM THERAPEUTICS INC. (Registrant)
April 6, 2011 (Date)	/s/ YAKY YANAY Yaky Yanay Chief Financial Officer

Exhibit Listing

Exhibit Index
99.1	Press release dated April 6, 2011